Histiocytosis Treatments
Find Histiocytosis Treatments
Brand Name
Aqneursa
Generic Name
Levacetylleucine
View Brand Information FDA approval date: September 24, 2024
Form: Granule
What is Aqneursa (Levacetylleucine)?
AQNEURSA™ is indicated for the treatment of neurological manifestations of Niemann-Pick disease type C in adults and pediatric patients weighing ≥15 kg. AQNEURSA is indicated for the treatment of neurological manifestations of Niemann-Pick disease type C in adults and pediatric patients weighing ≥15 kg.
Approved To Treat
Top Global Experts
There are no experts for this drug
Save this treatment for later
Not sure about your diagnosis?
Tired of the same old research?
Related Clinical Trials
There is no clinical trials being done for this treatment